Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder

NCT00100776 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: Olanzapine

Sponsor

Eli Lilly and Company